The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by RFA-NS-21-010.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,483,922 in first-year total cost, median $1,584,390.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-H (05)]2
- Special Emphasis Panel[ZNS1 SRB-H (07)]2
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- VANDERBILT UNIVERSITY1
- WEILL MEDICAL COLL OF CORNELL UNIV1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Novel HCN1-selective small molecule inhibitors for the treatment of neuropathic pain1UG3NS114947-01 | GOLDSTEIN, PETER A | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $1,757,406 | ZNS1 |
| 2019 | Novel mGlu5 negative allosteric modulators as first-in-class non-addictive analgesic therapeutics1UG3NS116218-01 | CONN, P JEFFREYGEREAU, ROBERT WLINDSLEY, CRAIGROOK, JERRI MICHELLE | VANDERBILT UNIVERSITY, TN | $1,585,635 | ZNS1 |
| 2019 | Development of MRGPRX1 positive allosteric modulators as non-addictive therapies for neuropathic pain1UG3NS115718-01 | TSUKAMOTO, TAKASHI | JOHNS HOPKINS UNIVERSITY, MD | $1,583,144 | ZNS1 |
| 2019 | Optimization of non-addictive biologics to target sodium channels involved in pain signaling1UG3NS114956-01 | WULFF, HEIKEYAROV-YAROVOY, VLADIMIR M | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $1,557,737 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.